BAMF Health
Curated by SignalDeveloper of AI-enabled molecular imaging and theranostics
Overview
Developer of AI-enabled molecular imaging and theranostics. The company is developing radiotracer using its radiotracer translational platform. The tracer will be used for non-invasive diagnostics for cancer, Alzheimer's, Parkinson's, and cardiac disease.
Key facts
- Founded
- 2018
- Headquarters
- Grand Rapids, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view